Effect of RBT-1 on Preconditioning Response Biomarkers in Subjects Undergoing CABG and/or Cardiac Valve Surgery

NCT04564833 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

152

Enrollment

INDUSTRY

Sponsor class

Conditions

AKI

Interventions

DRUG: Low Dose RBT-1
DRUG: High Dose RBT-1
DRUG: Placebo

Sponsor

Renibus Therapeutics, Inc.